PE(18:1/0:0)
|
Basic information |
| Metabolite name | PE(18:1/0:0) |
 | N/A |
 |
C00350 |
 |
N/A |
| Synonyms | NA |
| No. of studies | 3 |
|
Basic information |
| Metabolite name | PE(18:1/0:0) |
| N/A |
|
C00350 |
|
N/A |
| Synonyms | NA |
| No. of studies | 3 |
|
Relationship between PE(18:1/0:0) and depression (count: 3) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M076 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M076 | Type2 | CUMS + Anemarrhena saponins and Lilium saponins group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Down |
| Study M1024 | Type1 | CUMS group vs. control group | Serum | ICR mouse | Down |
| Study M1024 | Type2 | CUMS + hydroxytyrosol group vs. CUMS group | Serum | ICR mouse | Up |
| Study M464 | Type1 | drug-naive MDD group vs. control group | Plasma | Human | Up |
| Study M464 | Type1 | drug-treatment MDD group vs. control group | Plasma | Human | Up |